A new vaccine targeting the three most common human fungal infections is showing promising results in early preclinical studies. The data paves the …
Storyboard
First vaccine to target deadly fungal infections passes preclinical tests
A new vaccine targeting the three most common human fungal infections is showing promising results in early preclinical studies. The data paves the way for future human trials testing this pan-fungal vaccine in the hopes of preventing infections that have been linked to over one million deaths a year.
More fungus science
Storyboard
